会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • MEDICAMENT DELIVERY DEVICE
    • 药物输送装置
    • WO2015063462A2
    • 2015-05-07
    • PCT/GB2014/053193
    • 2014-10-27
    • CONSORT MEDICAL PLC
    • WILLOUGHBY, AlastairHOWARTH, BradANDERSON, IanKOPPELMAN, Rachel
    • A61M5/145
    • A61M5/14526A61M5/1454A61M5/16877A61M5/31515A61M2005/14513A61M2005/2086A61M2205/3334A61M2206/22
    • A medicament delivery device comprising a first container having a delivery outlet at a front end thereof and a first stopper axially moveable in the first container, the first stopper defining and separating a first chamber and a second chamber in the first container, where the first chamber is axially forwards of the first stopper and the second chamber is axially rearwards of the first stopper. The medicament delivery device further comprising a second container having a second stopper axially moveable in the second container, the second stopper defining and separating a third chamber and a fourth chamber in the second container, where the third chamber is axially forwards of the second stopper and the fourth chamber is axially rearwards of the second stopper, and where the third chamber has a vent outlet in fluid communication with a venting chamber. The first stopper is connected to the second stopper by a tensile member such that axially forwardly movement of the first stopper causes axially forwardly movement of the second stopper due to tensioning of the tensile member. The first stopper is driveable in an axially forwardly direction, the first chamber is configured to contain medicament for delivery through the delivery outlet as the first stopper moves axially forwards, the third chamber contains a viscous fluid that enters the venting chamber via the vent outlet as the second stopper moves axially forwards, and the fourth chamber has a pressure that is substantially equal to or greater than the pressure of the venting chamber. As the first stopper is driven axially forwardly, the tensile member is tensioned and causes the second stopper to move axially forwardly and the venting of viscous fluid into the venting chamber via the vent outlet retards the axially forward movement of the second stopper and the first stopper.
    • 药物输送装置,其包括第一容器和第二容器,第一容器在其前端具有输送出口,第一限位器可在第一容器中轴向移动,第一限位器限定并分隔第一腔室和第二腔室, 第一容器,其中第一腔室在第一止动件的轴向前方,并且第二腔室在第一止动件的轴向后方。 所述药物输送装置还包括第二容器,所述第二容器具有可在所述第二容器中轴向移动的第二止动件,所述第二止动件限定并分离所述第二容器中的第三腔室和第四腔室,其中所述第三腔室在所述第二止动件的轴向前方以及 第四腔室在第二止动件的轴向后方,并且第三腔室具有与排气室流体连通的排气出口。 第一止动件通过拉伸构件连接至第二止动件,使得第一止动件的轴向向前运动由于张力构件的张紧而引起第二止动件的轴向向前运动。 第一止动件可沿轴向向前方向驱动,第一腔室构造成容纳用于当第一止动件向前轴向移动时通过输送出口输送的药物,第三腔室容纳经由通气出口进入通气腔室的粘性流体,如 第二塞子轴向向前移动,并且第四腔室具有基本上等于或大于通气室的压力的压力。 当第一挡块被轴向向前驱动时,拉伸构件被张紧并且使得第二挡块轴向向前移动,并且粘性流体经由排气出口排出到排气室中阻止第二挡块和第一挡块的轴向向前移动
    • 6. 发明申请
    • FLUID RESTRICTION MECHANISMS FOR DRUG DELIVERY PUMPS
    • 用于药物输送泵的流体限制机构
    • WO2014116998A2
    • 2014-07-31
    • PCT/US2014/013019
    • 2014-01-24
    • UNITRACT SYRINGE PTY LTDO'CONNOR, Sean M.
    • O'CONNOR, Sean M.HANSON, Ian B.BENTE IV, Paul F.CLEMENTE, Matthew J.
    • A61M5/14
    • A61M5/16813A61M5/141A61M5/14248A61M5/1452A61M5/1454A61M5/16822A61M2205/13
    • A replaceable fluid restriction mechanism 500, 1500 includes: an aperture 520A residing adjacent to a fluid pathway connection and configured to permit flow of a drug fluid through the aperture 520A when the fluid pathway connection is open; an entry point 520B of a fluid channel 520C configured such that the flow of drug fluid can travel through aperture 520A to the entry point 520B and through the fluid channel 520C to an exit point 520D; and an outlet aperture 514 of a port 512 through which the flow of drug fluid may travel after exiting the exit point 520D, wherein a fluid conduit 30 is connected to the fluid restriction mechanism at the outlet aperture. A configurable fluid restriction mechanism 500, 1500 includes a plurality of fluid channels 520C, 521C, 522C, 523C, selectable to align with the entry point 520B and an exit point 520D of the fluid restriction mechanism.
    • 可替换的流体限制机构500,1500包括:邻近流体通路连接并且构造成允许药物流体在流体通路连接打开时通过孔520A流动的孔520A; 流体通道520C的入口点520B被配置为使得药物流体的流动可以通过孔520A行进到入口点520B并且通过流体通道520C行进到出口点520D; 以及端口512的出口孔514,药物流体的流动可以在离开出口点520D之后行进,其中流体导管30在出口孔处连接到流体限制机构。 可配置流体限制机构500,1500包括多个流体通道520C,521C,522C,523C,其可选择地与流体限制机构的入口点520B和出口点520D对准。
    • 8. 发明申请
    • ADHESIVE ASSEMBLIES AND MICRONEEDLE INJECTION APPARATUSES COMPRISING SAME
    • 粘合组件和包含相同的麦克风注射装置
    • WO2014099404A1
    • 2014-06-26
    • PCT/US2013/073451
    • 2013-12-06
    • 3M INNOVATIVE PROPERTIES COMPANY
    • BURTON, Scott, A.NG, Chin-Yee
    • A61M37/00A61M25/02A61M5/158A61M5/142
    • A61M37/0015A61M5/14248A61M5/1454A61M2005/1585A61M2025/0273A61M2037/0023A61M2037/003A61M2209/088
    • Adhesive assemblies and microneedle injection apparatuses comprising same. The apparatus (100) can include a housing (102) having a base and an opening (115) formed in the base; and an applicator comprising a microneedle array (104), the microneedle array comprising a first major surface (111) and microneedles (105). The applicator can be movable between a first position, and a second position in which at least a portion of the microneedle array extends through the opening in the base. The apparatus can further include an adhesive assembly (118), which can be adhered to the base of the housing. The adhesive assembly can include an extension (125) that extends at least partially into the area defined by the opening, such that when the applicator is in the second position, at least a portion of the first major surface of the microneedle array is in contact with the extension of the adhesive assembly.
    • 粘合剂组合物和包含其的微针注射装置。 设备(100)可以包括具有底座和形成在基座中的开口(115)的壳体(102) 和包括微针阵列(104)的涂抹器,所述微针阵列包括第一主表面(111)和微针(105)。 施用器可以在第一位置和第二位置之间移动,其中微针阵列的至少一部分延伸穿过基座中的开口。 该装置还可以包括粘合剂组件(118),其可以粘附到壳体的基部。 粘合剂组件可以包括至少部分地延伸到由开口限定的区域中的延伸部(125),使得当施用器处于第二位置时,微针阵列的第一主表面的至少一部分接触 随着粘合剂组件的延伸。